Andrew Farquharson - Jul 29, 2021 Form 3/A - Amendment Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Role
Director
Signature
/s/ Josh Seidenfeld, Attorney-in-Fact for Andrew Farquharson
Stock symbol
RANI
Transactions as of
Jul 29, 2021
Transactions value $
$0
Form type
3/A - Amendment
Date filed
8/2/2021, 07:36 PM
Date Of Original Report
Jul 29, 2021
Next filing
Feb 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RANI Class A Common Stock 829K Jul 29, 2021 See footnote F1, F2
holding RANI Class B Common Stock 2.56M Jul 29, 2021 See footnote F1, F3
holding RANI Class B Common Stock 187K Jul 29, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RANI Class A Common LLC Units Jul 29, 2021 Class A Common Stock 2.56M See footnote F1, F3, F4
holding RANI Class A Common LLC Units Jul 29, 2021 Class A Common Stock 430K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed to correctly reflect the shares held directly and indirectly.
F2 Represents 378,533 shares of Class A Common Stock of the Issuer ("Class A Shares") held by Biologix Partners, LP and 450,902 Class A Shares held by VH Rani, LP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
F3 Represents 2,492,441 shares of Class B Common Stock of the Issuer ("Class B Shares") held by InCube Ventures II, L.P. and 72,420 Class B Shares held by Rani Investment Corp. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
F4 Represents Common LLC Units of Rani Therapeutics, LLC, a direct subsidiary of the Issuer. The Common LLC Units are redeemable at the election of the Reporting Person at any time for newly-issued Class A Shares on a one-for-one basis or, if mutually agreed with the Issuer, a cash payment equal to the volume weighted average market price of one Class A Share for each Common LLC Unit redeemed (subject to customary adjustments, including for stock splits, stock dividends and reclassifications). However, the Issuer may elect to effect a direct exchange of such Class A Shares (or such cash, if mutually agreed) for such Common LLC Units.